Carlyle in talks to invest $100 million in BDR Pharma

BDR clocked Rs 550-600 crore in revenue and around Rs 120 crore in FY18 EBITDA.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2Ov3rfI
via IFTTT

0 comments:

Post a Comment